Record Quarterly Sales
Q1 2026 sales of $156 million, an 11% increase year-over-year (pro forma).
Record Adjusted EBITDA and Margin
Adjusted EBITDA increased by $20 million versus prior-year quarter and adjusted EBITDA margin reached a record 40.5%, up 290 basis points year-over-year.
Strong Adjusted Net Income Growth
Adjusted net income increased by $5 million, or 20% year-over-year (adjusted to exclude non-cash amortization and certain non-recurring charges).
Exceptional Cash Conversion
Cash conversion coverage to net income was 230%, indicating strong cash generation relative to earnings.
Robust New Business Pipeline
Organic new business pipeline ≈ $700 million (up ~$100 million since February), with slightly more than half tied to commercial end market; management notes that converting less than 15% of this pipeline over time would support targeted ~3% annual growth from new business.
Balanced End-Market Performance
Commercial aftermarket sales +11% and commercial OEM sales +18% year-over-year; commercial strength more than offset defense weakness in the quarter.
Raised Full-Year Guidance
2026 guidance increased by $5 million of sales and $4 million of adjusted EBITDA. New full-year ranges: net sales $645M–$655M; adjusted EBITDA $257M–$262M; adjusted EBITDA margin ≈ 40%; adjusted EPS $1.26–$1.30; capex ≈ $19M (~3% of sales).
Long-Term Track Record and Ambitious Targets
Since inception (2012) through end of 2025, sales and adjusted EBITDA grew at CAGRs of >30% and >40%, respectively. Management reiterated organic targets of 10%+ sales growth and 15%+ adjusted EBITDA growth annually and a plan to triple adjusted EBITDA every five years (including acquisitions).
Strong Backlog and Book-to-Bill
Overall book-to-bill >1.2x; defense book-to-bill was the highest among end markets and the company ended the quarter with record defense backlog despite near-term defense sales softness.